186 related articles for article (PubMed ID: 35058480)
1. Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases.
Zhu X; Wang Y; Xiao Y; Gao Q; Gao L; Zhang W; Xin X; Chen K; Srivastava U; Ginjupalli VKM; Cupelli M; Lazzerini PE; Capecchi PL; Chen L; Boutjdir M
Sci Rep; 2022 Jan; 12(1):1075. PubMed ID: 35058480
[TBL] [Abstract][Full Text] [Related]
2. The impact of hydroxychloroquine-azithromycin combination on Tpeak-to-end and Tpeak-to-end/QT ratio during a short treatment course.
Bakhshaliyev N; Özdemir R
Ann Noninvasive Electrocardiol; 2021 Jul; 26(4):e12846. PubMed ID: 33956361
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE
JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708
[TBL] [Abstract][Full Text] [Related]
5. System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation.
Khan AA; Khan Z
Chem Biol Interact; 2020 Dec; 332():109299. PubMed ID: 33098839
[TBL] [Abstract][Full Text] [Related]
6. The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients.
Bakhshaliyev N; Uluganyan M; Enhos A; Karacop E; Ozdemir R
J Electrocardiol; 2020; 62():59-64. PubMed ID: 32827987
[TBL] [Abstract][Full Text] [Related]
7. Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen.
Bernardini A; Ciconte G; Negro G; Rondine R; Mecarocci V; Viva T; Santini F; de Innocentiis C; Giannelli L; Witkowska E; Locati ET; Castelvecchio S; Marrocco-Trischitta MM; Vicedomini G; Menicanti L; Pappone C
Int J Cardiol; 2021 Feb; 324():242-248. PubMed ID: 32956782
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Safety of Hydroxychloroquine-Azithromycin in 424 COVID-19 Patients.
Million M; Lagier JC; Hourdain J; Franceschi F; Deharo JC; Parola P; Brouqui P
Medicina (Kaunas); 2023 Apr; 59(5):. PubMed ID: 37241095
[No Abstract] [Full Text] [Related]
9. Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings.
Gasperetti A; Biffi M; Duru F; Schiavone M; Ziacchi M; Mitacchione G; Lavalle C; Saguner A; Lanfranchi A; Casalini G; Tocci M; Fabbricatore D; Salghetti F; Mariani MV; Busana M; Bellia A; Cogliati CB; Viale P; Antinori S; Galli M; Galiè N; Tondo C; Forleo GB
Europace; 2020 Dec; 22(12):1855-1863. PubMed ID: 32971536
[TBL] [Abstract][Full Text] [Related]
10. Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case.
Montnach J; Baró I; Charpentier F; De Waard M; Loussouarn G
Europace; 2021 Jul; 23(7):1124-1133. PubMed ID: 34009333
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues.
Wong AO; Gurung B; Wong WS; Mak SY; Tse WW; Li CM; Lieu DK; Costa KD; Li RA; Hajjar RJ
J Mol Cell Cardiol; 2021 Apr; 153():106-110. PubMed ID: 33373642
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY
JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991
[TBL] [Abstract][Full Text] [Related]
14. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19.
Koh HM; Chong PF; Tan JN; Chidambaram SK; Chua HJ
J Clin Pharm Ther; 2021 Jun; 46(3):800-806. PubMed ID: 33768612
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.
Gopinathannair R; Merchant FM; Lakkireddy DR; Etheridge SP; Feigofsky S; Han JK; Kabra R; Natale A; Poe S; Saha SA; Russo AM
J Interv Card Electrophysiol; 2020 Nov; 59(2):329-336. PubMed ID: 32494896
[TBL] [Abstract][Full Text] [Related]
16. Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
Echarte-Morales J; Minguito-Carazo C; Del Castillo-García S; Borrego-Rodríguez J; Rodríguez-Santamarta M; Sánchez-Muñoz E; Bergel-García R; González-Maniega C; Prieto-González S; Menéndez-Suarez P; Tundidor-Sanz E; Benito-González T; Fernández-Vázquez F
J Electrocardiol; 2021; 64():30-35. PubMed ID: 33307378
[TBL] [Abstract][Full Text] [Related]
17. Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study.
El Kadri M; Al Falasi O; Ahmed R; Al Awadhi A; Altaha Z; Hillis A; Panikkaveetil B; Abdalla S; Ansel Benette H; Almubarak A; Saifuddin M; Alattar Y; Oulhaj A; AlKaabi S
BMJ Open; 2022 Feb; 12(2):e051579. PubMed ID: 35140148
[TBL] [Abstract][Full Text] [Related]
18. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
Sarayani A; Cicali B; Henriksen CH; Brown JD
Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
[TBL] [Abstract][Full Text] [Related]
19. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
[TBL] [Abstract][Full Text] [Related]
20. Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19.
Gunay S; Caliskan S; Sigirli D; Sahin E
Bratisl Lek Listy; 2020; 121(11):817-821. PubMed ID: 33164544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
